Decision making in chronic subdural haematoma patient referrals in an octogenarian and nonagenarian population - a

Joshua MacArthur1, Sayan Biswas2, Lareyna McMenemy1

  • 1Faculty of Biology, Medicine and Health, University of Manchester, Manchester, Greater Manchester, UK.

Insights

Chronic subdural haematoma (CSDH) referral acceptance is lower in the very elderly. CSDH size and premorbid quality of life (QoL) are key predictors for neurosurgical intervention in all age groups.

Area of Science:

  • Neurosurgery
  • Geriatric Medicine
  • Public Health

Background:

  • Chronic subdural haematoma (CSDH) incidence is increasing among the elderly population.
  • Limited research exists on CSDH management in patients over 80.
  • Referral acceptance by tertiary centers dictates neurosurgical intervention in the UK.

Purpose of the Study:

  • To identify predictors of neurosurgical referral acceptance for chronic subdural haematoma (CSDH) in octogenarian and nonagenarian patients.
  • To compare referral acceptance predictors between ultra-elderly (≥80 years) and adult (<80 years) populations.
  • To analyze the influence of age, clinical presentation, CSDH characteristics, and premorbid quality of life (QoL) on referral acceptance.

Main Methods:

  • A multi-center retrospective case series analysis (January 2015 - May 2020).
  • Patients categorized as adult (<80 years) or ultra-geriatric (≥80 years), with further subgrouping into octogenarians (80-89) and nonagenarians (≥90).
  • Multivariable logistic regression utilized to assess predictors including age, headache, dementia, motor weakness, midline shift, CSDH size, and premorbid QoL.

Main Results:

  • Referral acceptance was significantly lower in ultra-geriatric patients (22.4%) compared to adults (38.1%) and in nonagenarians (10.5%) versus octogenarians (27.7%).
  • CSDH size and premorbid QoL were consistent independent predictors of acceptance across all age groups.
  • Predictor significance varied by age group; in nonagenarians, only age, CSDH size, and QoL were significant.

Conclusions:

  • CSDH size and premorbid QoL are crucial independent predictors for neurosurgical referral acceptance in all age groups.
  • These factors are particularly important for the octogenarian and nonagenarian populations.
  • Other clinical variables demonstrate age-dependent significance in predicting referral acceptance for CSDH management.
Abstract

Related Concept Videos

Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Ethical Dilemmas II01:30

Ethical Dilemmas II

Resolving an ethical dilemma in healthcare involves a systematic approach that considers every aspect of the issue, respecting both the patient's needs and values and the healthcare professional's ethical obligations. Here are potential steps to resolve an ethical dilemma:
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...